Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Mason

Showing results (421-430 of 435) with videos related to

Pageof 44
Sort By:
Multiple Sclerosis and Related Disorders|February 26, 2022
Response to treatment in NMOSD: the Australasian experienceLaura Clarke, Wajih Bukhari, Cullen M O'Gorman, et al.
The Journal of Clinical Investigation|November 15, 2023
LAIR-1 agonism as a therapy for acute myeloid leukemiaRustin R Lovewell, Junshik Hong, Subhadip Kundu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2023
PI3K Inhibition Restores and Amplifies Response to Ruxolitinib in Patients with MyelofibrosisTamara K Moyo, Ashwin Kishtagari, Matthew T Villaume, et al.
Plos One|July 5, 2013
Gauging NOTCH1 Activation in Cancer Using ImmunohistochemistryMichael J Kluk, Todd Ashworth, Hongfang Wang, et al.
Journal of Neurochemistry|September 18, 2025
Embracing Scientific Debate in Brain MetabolismJens V Andersen, Blanca I Aldana, Lasse K Bak, et al.
Nature|April 8, 2021
Cell-programmed nutrient partitioning in the tumour microenvironmentBradley I Reinfeld, Matthew Z Madden, Melissa M Wolf, et al.
Nature Nanotechnology|July 31, 2024
Polymersomes with splenic avidity target red pulp myeloid cells for cancer immunotherapyAnnelies C Wauters, Jari F Scheerstra, Mandy M T van Leent, et al.
The Medical Journal of Australia|February 9, 2025
Consensus recommendations on multiple sclerosis management in Australia and New Zealand: part 2Jessica Shipley, James Beharry, Wei Yeh, et al.
The Medical Journal of Australia|February 9, 2025
Consensus recommendations on multiple sclerosis management in Australia and New Zealand: part 1Jessica Shipley, James Beharry, Wei Yeh, et al.
Journal of Neurology|February 2, 2020
The clinical profile of NMOSD in Australia and New ZealandWajih Bukhari, Laura Clarke, Cullen O'Gorman, et al.
Pageof 44

Showing results (421-430 of 435) with videos related to

Sort By:
Pageof 44
Multiple Sclerosis and Related Disorders|February 26, 2022
Response to treatment in NMOSD: the Australasian experienceLaura Clarke, Wajih Bukhari, Cullen M O'Gorman, et al.
The Journal of Clinical Investigation|November 15, 2023
LAIR-1 agonism as a therapy for acute myeloid leukemiaRustin R Lovewell, Junshik Hong, Subhadip Kundu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2023
PI3K Inhibition Restores and Amplifies Response to Ruxolitinib in Patients with MyelofibrosisTamara K Moyo, Ashwin Kishtagari, Matthew T Villaume, et al.
Plos One|July 5, 2013
Gauging NOTCH1 Activation in Cancer Using ImmunohistochemistryMichael J Kluk, Todd Ashworth, Hongfang Wang, et al.
Journal of Neurochemistry|September 18, 2025
Embracing Scientific Debate in Brain MetabolismJens V Andersen, Blanca I Aldana, Lasse K Bak, et al.
Nature|April 8, 2021
Cell-programmed nutrient partitioning in the tumour microenvironmentBradley I Reinfeld, Matthew Z Madden, Melissa M Wolf, et al.
Nature Nanotechnology|July 31, 2024
Polymersomes with splenic avidity target red pulp myeloid cells for cancer immunotherapyAnnelies C Wauters, Jari F Scheerstra, Mandy M T van Leent, et al.
The Medical Journal of Australia|February 9, 2025
Consensus recommendations on multiple sclerosis management in Australia and New Zealand: part 2Jessica Shipley, James Beharry, Wei Yeh, et al.
The Medical Journal of Australia|February 9, 2025
Consensus recommendations on multiple sclerosis management in Australia and New Zealand: part 1Jessica Shipley, James Beharry, Wei Yeh, et al.
Journal of Neurology|February 2, 2020
The clinical profile of NMOSD in Australia and New ZealandWajih Bukhari, Laura Clarke, Cullen O'Gorman, et al.
Pageof 44